BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Navidea Biopharmaceuticals 

425 Metro Place Northurt
Suite 400
Dublin  Ohio  43017  U.S.A.
Phone: 614-793-7500 Fax: 614 793 7520


SEARCH JOBS




Industry
Medical Device






 Company News
Navidea Biopharmaceuticals (NAVB) To Announce Second Quarter 2014 Financial Results On August 6, 2014 7/29/2014 9:48:47 AM
Navidea Biopharmaceuticals (NAVB) Announces 2014 Annual Meeting Results 7/18/2014 10:11:05 AM
Navidea Biopharmaceuticals (NAVB) Joins Essex Woodland’s Rheumco To Develop Radiopharmaceuticals For Detection And Treatment Of Arthritic Diseases 7/16/2014 9:38:38 AM
Navidea Biopharmaceuticals (NAVB) To Webcast Investor Briefing On Sentinel Lymph Node Biopsy In Head & Neck Cancers July 8, 2014 7/3/2014 6:41:28 AM
Navidea Biopharmaceuticals (NAVB) To Present At The 9th Annual JMP Securities Healthcare Conference 6/18/2014 11:23:51 AM
Navidea Biopharmaceuticals (NAVB) Release: FDA Approves Lymphoseek To Help Determine The Extent Of Head And Neck Cancer In The Body 6/13/2014 9:58:39 AM
Navidea Biopharmaceuticals (NAVB)’ Lymphoseek® (technetium Tc 99m tilmanocept) Injection Demonstrates Preferential Accumulation In Tumor-Positive Sentinel Lymph Nodes In Post-Hoc Analysis 6/11/2014 8:09:25 AM
Navidea Biopharmaceuticals (NAVB) Announces Positive Lymphoseek® (Technetium Tc 99m Tilmanocept) Injection Results On Injection Timing And Surgery Across Multiple Solid Tumor Types 6/11/2014 6:30:37 AM
Navidea Biopharmaceuticals (NAVB) Announces Data Demonstrating Potential Of Manocept™ Platform To Diagnose Rheumatoid Arthritis And Kaposi's Sarcoma 6/10/2014 6:47:53 AM
Navidea Biopharmaceuticals (NAVB) To Present At The Jefferies and Co. 2014 Global Healthcare Conference 5/29/2014 7:38:26 AM
12345678910...